Ascendis Pharma A/S vs Ross Stores, Inc. — how do they compare? Ascendis Pharma A/S trades at $254.5 (market cap $16.67B), while Ross Stores, Inc. trades at $251.3 (market cap $80.78B). The key difference: Ross Stores, Inc. is far larger — about 4.8× Ascendis Pharma A/S's market cap, and Ross Stores, Inc. pays a 0.71% dividend while Ascendis Pharma A/S pays none. Which is the better fit depends on your goals.
| ASND | ROST | |
|---|---|---|
Market Cap | $16.67B | $80.78B |
Sector | Health | Consumer Cyclical |
52-Week High | $277.18 | $255.23 |
52-Week Low | $189.74 | $144.67 |
Enterprise Value | $17.04B | $81.37B |
Dividend Yield | — | 0.71% |
Trailing returns across standard periods
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →Ross Stores is a leading American off-price apparel and home fashion retailer, operating over 1,920 stores (at the end of fiscal 2021) across the Ross Dress for Less and dd's Discounts banners. Ross offers a variety of name-brand products and targets undercutting conventional retailers' regular prices by 20%-70%. The company uses an opportunistic, flexible merchandising approach
Read more on ROST →